January 24, 2011 – Boston Scientific has reached an agreement with Fukuda Denshi to market and sell its cardiac rhythm management (CRM) devices and accessories throughout Japan. Fukuda Denshi will begin distributing the CRM products this quarter.
Fukuda Denshi has been operating in Japan for more than 70 years.
For more information: www.bostonscientific.com
March 26, 2024 — UC San Diego Health is the first health system in San Diego to successfully implant the world’s first ...
March 26, 2024 
March 15, 2024 — Following the recent CE approval of the Solia S lead1 for LBBAP, BIOTRONIK proudly announces the world ...
March 15, 2024 
March 15, 2024 — Following the recent CE approval of the Solia S lead1 for LBBAP, Biotronik announces the world’s first ...
March 15, 2024 
January 5, 2024 — Medtronic, a global leader in healthcare technology, today announced it has received CE (Conformité ...
January 05, 2024 
August 21, 2023 — The first implant in Europe of Biotronik’s latest pacemaker and CRT-P generation was conducted in ...
August 21, 2023 
July 6, 2023 — BIOTRONIK announced U.S. Food and Drug Administration (FDA) approval of its portfolio of Amvia Edge ...
July 06, 2023 
July 5, 2023 — Abbott announced that the U.S. Food and Drug Administration (FDA) has approved the AVEIR dual chamber (DR ...
July 05, 2023 
June 1, 2023 — Every year more than one million people receive a pacemaker. Until now, leadless versions were only ...
June 01, 2023 
May 25, 2023 — Abbott announced late-breaking results from the AVEIR dual-chamber (DR) i2i Investigational Device ...
May 25, 2023 
May 12, 2023 — Biotronik, a leading global medical technology company with 60 years of experience in developing trusted ...
May 12, 2023